1189746-27-7,
2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-indazole,
2-METHYLINDAZOLE-5-BORONIC ACID PINACOL ESTER,
2-methyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-indazole,
(2-METHYL-2H-INDAZOL-5-YL)BORONIC ACID PINACOL ESTER,
SCHEMBL907049,
CTK6I3791,
DTXSID50656798,
PFZWGNKMAGHYBG-UHFFFAOYSA-N,
ZX-AT002590,
ANW-45518,
MFCD11109436,
AKOS005258526,
ZINC169745293,
FCH2836414,
OR30597,
PB26631,
RP06297,
KS-000003A4,
AK-40942,
AS-38159,
AB0035070,
AB1004432,
AX8167807,
TR-034340,
4CH-009196,
AM20020266,
CS-0051854,
FT-0685544,
ST24028095,
X9339,
A-2617,
A804138,
2-Methyl-2H-indazole-5-boronic acid pinacol ester,
J-509990,
2-methyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)indazole,
2-Methyl-2H-indazole-5-boronic acid pinacol ester, AldrichCPR,
2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazole,
2-methyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-2H-indazole,
2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H -indazole,
2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl);-2H-indazole,
2H-Indazole,2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-,
null,
C14H19BN2O2,
3-(Maleimido)propionic acid N-hydroxysuccinimide ester,
2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-indazole, 95% - 1G 1g,